Prime Medicine, Inc.PRMENASDAQ

Revenue (LTM)

$5M

+55.3% YoY

Net Income (LTM)

$-201M

-2.7% YoY

Free Cash Flow

$-167M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	3	5↑55.3%
Gross Profit	0	0	0	3	-3↓190.1%
Operating Income	-84	-117↓38.0%	-205↓75.7%	-202↑1.1%	-208↓2.9%
Net Income	-165	-122↑26.3%	-198↓62.6%	-196↑1.1%	-201↓2.7%
EBITDA	-84	-114↓36.2%	-187↓63.3%	-196↓5.2%	-196↑0.3%
EPS Diluted	-1.92	-1.46↑24.0%	-2.18↓49.1%	-1.65↑24.2%	-1.35↑18.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	185	188↑1.2%	42↓77.8%	182↑338.9%	63↓65.5%
Total Current Assets	271	297↑9.6%	143↓51.8%	212↑48.2%	181↓14.4%
Total Assets	302	360↑19.4%	194↓46.2%	298↑53.5%	343↑15.2%
Total Current Liabilities	58	27↓53.9%	56↑111.2%	38↓32.7%	37↓1.4%
Total Liabilities	62	44↓29.3%	61↑38.0%	144↑137.5%	222↑53.7%
Total Equity	240	316↑32.0%	133↓57.9%	153↑15.1%	121↓21.1%
Total Debt	10	29↑176.2%	14↓52.6%	41↑199.2%	116↑185.4%
Net Debt	-175	-159↑9.2%	-28↑82.4%	-142↓407.1%	53↑137.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-34	-132↓286.8%	-165↓25.5%	-123↑25.7%	-163↓32.3%
Capital Expenditure	-4	-16↓287.8%	-9↑45.8%	-7↑16.4%	-5↑37.9%
Free Cash Flow	-38	-148↓286.9%	-174↓17.7%	-130↑25.3%	-167↓28.4%
Stock-Based Comp	2	6↑269.9%	14↑115.4%	26↑87.4%	29↑12.3%
Net Change in Cash	162	3↓98.4%	-146↓5780.5%	141↑196.9%	-120↓184.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance